Proteomic profiling of extracellular vesicles and particles reveals the cellular response to cisplatin in NSCLC

BACKGROUND: Cisplatin‐based chemotherapy is a therapeutic strategy against non‐small cell lung cancer (NSCLC). However, cancers relapse after chemotherapy due to a dormant state of residual cancer cells. Extracellular vesicles and particles (EVPs) are active carriers of proteins and nucleic acid. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiaqi, Wang, Lujuan, Yin, Na, Chen, Anqi, Yi, Junqi, Tang, Jingqun, Xiang, Juanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487815/
https://www.ncbi.nlm.nih.gov/pubmed/34520129
http://dx.doi.org/10.1111/1759-7714.14147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487815/
https://www.ncbi.nlm.nih.gov/pubmed/34520129
http://dx.doi.org/10.1111/1759-7714.14147

Ejemplares similares